1. A novel technique to diagnose non‐melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors. Issue 9 (12th August 2019) Authors: Fujimura, Taku; Okabe, Takahiro; Tanita, Kayo; Sato, Yota; Lyu, Chunbing; Kambayashi, Yumi; Maruyama, Shigenao; Aiba, Setsuya Journal: Experimental dermatology Issue: Volume 28:Issue 9(2019) Page Start: 1029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cytotoxic antimelanoma drugs suppress the activation of M2 macrophages. Issue 1 (26th October 2017) Authors: Fujimura, Taku; Kakizaki, Aya; Kambayashi, Yumi; Sato, Yota; Tanita, Kayo; Lyu, Chunbing; Furudate, Sadanori; Aiba, Setsuya Journal: Experimental dermatology Issue: Volume 27:Issue 1(2018) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased expression of dermal LL37 may trigger migration of CCR7+ regulatory T cells in extramammary Paget's disease. Issue 1 (July 2020) Authors: Lyu, Chunbing; Fujimura, Taku; Amagai, Ryo; Ohuchi, Kentaro; Sato, Yota; Tanita, Kayo; Matsushita, Shigeto; Fujisawa, Yasuhiro; Otsuka, Atsushi; Yamamoto, Yuki; Takahashi, Toshiya; Aiba, Setsuya Journal: Journal of dermatological science Issue: Volume 99:Issue 1(2020) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Increased serum CCL26 level is a potential biomarker for the effectiveness of anti-PD1 antibodies in patients with advanced melanoma. Issue 6 (December 2020) Authors: Fujimura, Taku; Tanita, Kayo; Ohuchi, Kentaro; Sato, Yota; Lyu, Chunbing; Kambayashi, Yumi; Fujisawa, Yasuhiro; Tanaka, Ryota; Hashimoto, Akira; Aiba, Setsuya Journal: Melanoma research Issue: Volume 30:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Minocycline decreases Th2 chemokines from M2 macrophages: Possible mechanisms for the suppression of bullous pemphigoid by traditional bullous disease drugs. Issue 11 (9th October 2018) Authors: Tanita, Kayo; Fujimura, Taku; Sato, Yota; Lyu, Chunbing; Aiba, Setsuya Journal: Experimental dermatology Issue: Volume 27:Issue 11(2018) Page Start: 1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pembrolizumab resolves adult ashy dermatosis developing in patients with squamous cell carcinoma of the lung. Issue 3 (21st January 2019) Authors: Takeda, Kana; Fujimura, Taku; Tsuchiyama, Kenichiro; Lyu, Chunbing; Aiba, Setsuya Journal: Journal of dermatology Issue: Volume 46:Issue 3(2019) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phosphor‐signal transducers and activator of transcription 1 signaling in mucosal lichen planus developing from metastatic bladder cancer treated with pembrolizumab. Issue 4 (5th May 2021) Authors: Tamabuchi, Erika; Fujimura, Taku; Lyu, Chunbing; Aiba, Setsuya Journal: Dermatologic therapy Issue: Volume 34:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid. Issue 3 (2nd December 2020) Authors: Ohuchi, Kentaro; Fujimura, Taku; Lyu, Chunbing; Amagai, Ryo; Muto, Yusuke; Aiba, Setsuya Journal: Journal of dermatology Issue: Volume 48:Issue 3(2021) Page Start: 353 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Serum CCL22 levels decreased in parallel with disease activity in CCR4‐positive mycosis fungoides treated with mogamulizumab. Issue 6 (17th August 2020) Authors: Ohuchi, Kentaro; Fujimura, Taku; Lyu, Chunbing; Amagai, Ryo; Muto, Yusuke; Aiba, Setsuya Journal: Dermatologic therapy Issue: Volume 33:Issue 6(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Severe eczematoid and lichenoid eruption with full‐thickness epidermal necrosis developing from metastatic urothelial cancer treated with enfortumab vedotin. Issue 12 (29th August 2020) Authors: Sasaki, Rui; Fujimura, Taku; Lyu, Chunbing; Aiba, Setsuya Journal: Journal of dermatology Issue: Volume 47:Issue 12(2020) Page Start: 1436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗